Literature DB >> 27576004

AHR2 morpholino knockdown reduces the toxicity of total particulate matter to zebrafish embryos.

Andrey Massarsky1, Audrey J Bone2, Wu Dong3, David E Hinton2, G L Prasad4, Richard T Di Giulio2.   

Abstract

The zebrafish embryo has been proposed as a 'bridge model' to study the effects of cigarette smoke on early development. Previous studies showed that exposure to total particulate matter (TPM) led to adverse effects in developing zebrafish, and suggested that the antioxidant and aryl hydrocarbon receptor (AHR) pathways play important roles. This study investigated the roles of these two pathways in mediating TPM toxicity. The study consisted of four experiments. In experiment I, zebrafish embryos were exposed from 6h post fertilization (hpf) until 96hpf to TPM0.5 and TPM1.0 (corresponding to 0.5 and 1.0μg/mL equi-nicotine units) in the presence or absence of an antioxidant (N-acetyl cysteine/NAC) or a pro-oxidant (buthionine sulfoximine/BSO). In experiment II, TPM exposures were performed in embryos that were microinjected with nuclear factor erythroid 2-related factor 2 (Nrf2), AHR2, cytochrome P450 1A (CYP1A), or CYP1B1 morpholinos, and deformities were assessed. In experiment III, embryos were exposed to TPM, and embryos/larvae were collected at 24, 48, 72, and 96hpf to assess several genes associated with the antioxidant and AHR pathways. Lastly, experiment IV assessed the activity and protein levels of CYP1A and CYP1B1 after exposure to TPM. We demonstrate that the incidence of TPM-induced deformities was generally not affected by NAC/BSO treatments or Nrf2 knockdown. In contrast, AHR2 knockdown reduced, while CYP1A or CYP1B1 knockdowns elevated the incidence of some deformities. Moreover, as shown by gene expression the AHR pathway, but not the antioxidant pathway, was induced in response to TPM exposure, providing further evidence for its importance in mediating TPM toxicity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AHR pathway; Cigarette smoke; Oxidative stress; Total particulate matter (TPM); Zebrafish development

Mesh:

Substances:

Year:  2016        PMID: 27576004     DOI: 10.1016/j.taap.2016.08.024

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Developmental Regulation of Nuclear Factor Erythroid-2 Related Factors (nrfs) by AHR1b in Zebrafish (Danio rerio).

Authors:  Alexandra Ulin; Jake Henderson; Minh-Tam Pham; James Meyo; Yuying Chen; Sibel I Karchner; Jared V Goldstone; Mark E Hahn; Larissa M Williams
Journal:  Toxicol Sci       Date:  2019-02-01       Impact factor: 4.849

Review 2.  Animal Model Contributions to Primary Congenital Glaucoma.

Authors:  Qiongrong Xia; Dingding Zhang; Yue Zhuang; Yuqian Dai; Haiping Jia; Qiu Du; Taishen Wen; Yuanyuan Jiang
Journal:  J Ophthalmol       Date:  2022-05-26       Impact factor: 1.974

3.  The utility of alternative models in particulate matter air pollution toxicology.

Authors:  Jacob Smoot; Stephanie Padilla; Aimen K Farraj
Journal:  Curr Res Toxicol       Date:  2022-05-27

4.  Development of a high-throughput in vivo screening platform for particulate matter exposures.

Authors:  Courtney Roper; Staci L Massey Simonich; Robert L Tanguay
Journal:  Environ Pollut       Date:  2018-02-21       Impact factor: 8.071

5.  A Review of the Functional Roles of the Zebrafish Aryl Hydrocarbon Receptors.

Authors:  Prarthana Shankar; Subham Dasgupta; Mark E Hahn; Robyn L Tanguay
Journal:  Toxicol Sci       Date:  2020-12-01       Impact factor: 4.849

6.  A Novel In Vivo Model to Study Impaired Tissue Regeneration Mediated by Cigarette Smoke.

Authors:  Marjorie Alvarez; Myra N Chávez; Miguel Miranda; Geraldine Aedo; Miguel L Allende; José T Egaña
Journal:  Sci Rep       Date:  2018-07-19       Impact factor: 4.379

Review 7.  Zebrafish Models of Craniofacial Malformations: Interactions of Environmental Factors.

Authors:  S T Raterman; J R Metz; Frank A D T G Wagener; Johannes W Von den Hoff
Journal:  Front Cell Dev Biol       Date:  2020-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.